Skip to content

Bone Disease in Severely Burned Children

Bone Disease in Severely Burned Children

Status
Terminated
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00591162
Enrollment
254
Registered
2008-01-11
Start date
1992-10-31
Completion date
2008-06-30
Last updated
2014-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn

Keywords

Bone, Dexa, Parathyroid, Diuretic, Tetracycline

Brief summary

Bone metabolism is adversely affected by severe burns in children for a period of time.

Detailed description

More closely monitored biochemical and radiologic parameters of bone and mineral metabolism will increase the likelihood of earlier detection of abnormalities and possible therapeutic interventions.

Interventions

DRUGTetracycline

Two courses of IV Tetracycline(10mg./kg./day for two days)separated by a two week interval.

RADIATIONDuel Energy X-Ray Absorptiometry (DEXA)

DEXA before discharge from acute admission and again one year post burn.

PROCEDUREBone Biopsy

Bone biopsy to be taken in the operation room at the last skin grafting operation at the site of the iliac crest. A second bone biopsy will be taken one year later post discharge from the acute admission.

Sponsors

The University of Texas Medical Branch, Galveston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children age 5-18 years old with at least 40% or more of their body burned.

Exclusion criteria

* Anyone with a burn covering less than 40% of the body or whose burn covers the front of both hipbones. * Anyone younger than 5 years old, anyone with a history of cancer or other metabolic disease process, or anyone who is pregnant or has an allergy to Tetracycline will also be excluded. * Anyone who has participated in an investigational drug trial within the past 60 days from date of admission will be excluded from this study.

Design outcomes

Primary

MeasureTime frame
Determine Bone Health(bone growth,strength,and content) in burn injured patients.Admission to Burn Unit up to eighteen years old.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026